The present disclosure is generally directed to patient monitoring systems and particularly to a system and method for monitoring patients in a manner which prevents or reduces patient falls.
According to recent studies, falls are a leading cause of death among people over the age of 65 years and 10% of the fatal falls for patients over 65 years of age occur in a hospital setting. For the general population, studies estimate that patient falls occur in 1.9 to 3% of all acute care hospitalizations. Of these hospital-based falls, approximately 30% will result in a serious injury with the cost to care for these injuries estimated to reach $54.9 billion per year by 2020. Current technologies that exist to assist in the prevention of falls are limited in their capabilities. These include pressure pads on the bed that trigger an alert when no pressure is detected on the pad, pressure pads on the floor and light beams that create a perimeter with alarms going off upon interruption of the beam. The pressure pads are ineffective as they do not prevent the fall but rather alert after the fact when it is too late. Additionally they are prone to false positive alerts. The light beams are also prone to false alerts when the patient or visitor simply reaches through it or the caregiver breaks the beam while delivering medication, food, drink or conducting a procedure on the patient. The present disclosure is directed to addressing these above-described shortcomings with current technology.
Generally disclosed is a novel method and system that allows healthcare providers, hospitals, skilled nursing facilities and other persons to monitor disabled, elderly or other high-risk individuals and utilize the described technology to prevent or reduce falls and/or mitigate the impact of a fall by delivering automated notification of“at risk” behavior and/or falls by such an individual being monitored, especially falls and/or behavior where assistance is required, using a virtual blob detection system.
With skeletal tracking (which is not the detection method used with the current disclosure) there can be factors affecting the cameras/image-video quality which effect the ability of the detection/monitoring system to detect a skeleton. Such factors, especially in a hospital, include, but are not limited to, sheets/blankets covering a patient, trays positioned over the bed hiding the patient and the patient blending into the bed and not having a skeleton recognized. The present disclosure use of a virtual blob detection system addresses or at lease reduces the issues of where a skeleton cannot be recognized. Virtual blob detection relies on a 3D object detection which doesn't matter how much of the person is viewable by the camera or if other objects are blocking the view of the camera. Even in poor lighting condition the virtual blob detection system can still capture and/or recognize movement as the system can use an IR Depth Map to do the blob detection which doesn't rely on lighting conditions.
The following non-limiting definitions are provided as aid in understanding the disclosed novel method and system:
At step F1a, one or more 3D Camera, Motion and/or Sound sensors can be installed in the patient's or individual's room. At step F1b, the one or more 3D Camera, Motion and Sound sensors can be configured to recognize the area being monitored using 3-Dimensional areas as defined by x, y, and z coordinates in relation to the 3D Camera, Motion and/or Sound Sensor. Based on the data sent/captured by the 3D Camera, Motion and/or Sound Sensor(s), the computerized virtual blob detection monitoring system is programmed to recognize any 3D object within the configured area. The patient's body is recognized and tracked as one or more blobs. Virtual blob detection zones can also be calibrated at this time. At step F1c, data from the 3D Camera, Motion and Sound sensors can be continuously sent to a Computerized Virtual Blob Detection Monitoring System preferably at all times while the system is being used for monitoring. At step F1d, a continuous video feed can be sent to the Central Monitoring Primary Display preferably at all times while the system is being used for monitoring.
At step F1e, if the computerized virtual blob detection monitoring system does not detect that the patient or any part of the patient (i.e. presented as a blob object(s)) has crossed into the designated virtual blob detection zone, it will continue monitoring. As a non-limiting example, if both hands of the patient enter the blob detection zone, the system may display and/or track as two different blobs or possibly as a single blob depending on how close the hands are to each other. If the computerized virtual blob detection monitoring system detects that the patient or any part of the patient has crossed into the designated virtual blob detection zone, it will then proceed to step F1f to determine how large the portion of the patient's body that entered the blob detection zone is. If the size of the patient's body that entered the blob detection zone is less than the configured minimum size, it will continue to monitor. Configuration is preferably through the detection system's programmed software and similar to how the zones, trip wires, etc. are configured. However, if the size of the patient's body that is within the blob detection zone is above the minimum predetermined or preprogrammed threshold for the object size, it can then proceed to step F1g. At step F1g, the system determines how long the patient's body has remained within the blob detection zone. If the patient's body has not remained in the detection zone for greater then a configured amount of time, preferably no alert is generated and the system continues to monitor (though the system can also be programmed to issue/generate an alert based solely on the system detecting a large enough blob within the detection zone for any period of time and such is also considered within the scope of the disclosure). However, if at step F1g, the patient's body has remained within the blob detection zone for greater then the minimum configured time period, the monitoring system will alert the computerized communication system. A record can also be entered in a database to record the incident. If other individuals such as a caregiver are also detected within the patient's/monitored room at the time the virtual blob detection zone threshold is crossed, the system can be designed or programmed such that no alert is generated and it will continue to monitor the data being sent from the 3D camera, motion and sound sensor. In this situation, generating an alarm/alert could result in a false alarm, given that there are other individual(s) with the patient, and such person(s) may be responsible for monitoring the patient and/or (even if not responsible) can assist the patient who is falling. The person in the room will be in a better position to assist the patient as compared to the individual located at the central monitoring station. It is also within the scope of the disclosure to send alarm/alerts even if other individual(s) are in the room with the patient, as those individuals may not be the person responsible, may be elderly, may have a physical handicap preventing them from stopping a patient from falling, etc.
At step F1h the computerized communication system preferably can first issue a verbal warning to the patient that they have entered the virtual blob detection zone. This verbal warning can be a pre-recorded message, including, but not limited to, a pre-recorded message from any caregiver, and will advise the patient to exit the virtual blob detection zone and return to their previous position. At step F1i, should the patient fail to exit the virtual blob detection zone and return to their previous position in a timely manner, an alert can be generated on the Central Monitoring Alert Display System (see
At step F1j, the computerized communication system can notify caregivers or other designated persons that the individual requires assistance. Notification of caregivers can be made through phone call, text messaging, speakerphone systems, pagers, email, or other electronic means of communication if so desired and configured. At step F1k, if the patient exits the virtual blob detection zone, the system database can be updated to reflect such. Additionally, the system will continue to monitor the patient and store all data in the system database.
At step F2b, all video, audio and alert feeds received by the centralized monitoring station can be displayed on the centralized monitoring primary display. Alternatively, multiple centralized monitoring primary displays can be utilized based on the quantity of rooms to be monitored at a given time. At step F2c, when the centralized monitoring system receives an alert from any of the computerized monitoring and communication systems indicating that an individual in any of the monitored rooms or other locations has fallen or otherwise entered into a detection zone, the video, audio and alert information for the specific room/individual is displayed on the Centralized Monitoring Alert Display. Should the centralized monitoring station receive alerts from more then one of the computerized monitoring and communication systems indicating that an individual in a monitored room or location has entered a virtual blob detection zone; the centralized monitoring alert display will display the video, audio and alerting information from all such instances at the same time. If no alert is received by the centralized monitoring station, preferably nothing is displayed on the Centralized Monitoring Alert Display. At step F2d, an electronic record of any alerts received by the Centralized Monitoring Station can be stored in an electronic database, which is in communication with the Centralized Monitoring Station.
As non-limiting examples, the icons that appear on the screen for selection can include the following symbols shown in
As seen in
As seen in
If there are any other types of zones or rails to draw for the particular sensor, the above steps are repeated to place the next zone or rail and the depth setting can be adjusted for each if necessary. Additionally, all zones and rails can be cleared by clicking on or otherwise selecting the Clear All icon in the toolbar. Once all of the zones/rails are configured, you can close the window to finish or you have the option to save the zone/rail configuration for later use.
As seen in
As seen in
As seen in
For certain Actions an additional field may need to be completed to finish the Action. If the field is required, it can appear below the Action dropdown (See
To add more Alerts, the user clicks or selects the Add button and repeats the above described steps. Once finished, the user clicks on or otherwise selects the bottom corner OK button to save and close the window.
In one non-limiting embodiment, for operation the disclosed system and method can use the following components:
1. One or more 3D Camera, Motion and/or Sound Sensors
2. A Computerized Virtual Blob Detection Monitoring System
3. A Computerized Communication System
4. A Centralized Monitoring Primary Display
5. A Centralized Monitoring Alert Display; and
6. Database
The various components can be in electrical and/or wireless communication with each other.
Located remote is defined to mean that the centralized monitoring station, centralized monitoring primary display and/or centralized monitoring alert display is not physically located within the monitored rooms. However, the location can be on the same premises at a different location (i.e. nurse station for the premises, hospital, etc.) or a different location (i.e. monitoring station, etc.).
The automatic detection of an individual entering a prescribed virtual blob detection zone will provide significant administrative and clinical benefits to caregivers and individuals alike, including the following non-limiting public benefits:
Any computer/server/electronic database system (collectively “Computer System”) capable of being programmed with the specific steps of the present invention can be used and is considered within the scope of the disclosure. Once programmed such Computer System can preferably be considered a special purpose computer limited to the use of two or more of the above particularly described combination of steps (programmed instructions) performing two or more of the above particularly described combination of functions.
All components of the present disclosure system and their locations, electronic communication methods between the system components, electronic storage mechanisms, etc. discussed above or shown in the drawings, if any, are merely by way of example and are not considered limiting and other component(s) and their locations, electronic communication methods, electronic storage mechanisms, etc. currently known and/or later developed can also be chosen and used and all are considered within the scope of the disclosure.
Unless feature(s), part(s), component(s), characteristic(s) or function(s) described in the specification or shown in the drawings for a claim element, claim step or claim term specifically appear in the claim with the claim element, claim step or claim term, then the inventor does not consider such feature(s), part(s), component(s), characteristic(s) or function(s) to be included for the claim element, claim step or claim term in the claim when and if the claim element, claim step or claim term is interpreted or construed. Similarly, with respect to any “means for” elements in the claims, the inventor considers such language to require only the minimal amount of features, components, steps, or parts from the specification to achieve the function of the “means for” language and not all of the features, components, steps or parts describe in the specification that are related to the function of the “means for” language.
While the disclosure has been described and disclosed in certain terms and has disclosed certain embodiments or modifications, persons skilled in the art who have acquainted themselves with the disclosure, will appreciate that it is not necessarily limited by such terms, nor to the specific embodiments and modification disclosed herein. Thus, a wide variety of alternatives, suggested by the teachings herein, can be practiced without departing from the spirit of the disclosure, and rights to such alternatives are particularly reserved and considered within the scope of the disclosure.
Number | Name | Date | Kind |
---|---|---|---|
4669263 | Sugiyama | Jun 1987 | A |
4857716 | Gombrich et al. | Aug 1989 | A |
5031228 | Lu | Jul 1991 | A |
5276432 | Travis | Jan 1994 | A |
5448221 | Weller | Sep 1995 | A |
5482050 | Smokoff et al. | Jan 1996 | A |
5592153 | Welling et al. | Jan 1997 | A |
5798798 | Rector et al. | Aug 1998 | A |
5838223 | Gallant et al. | Nov 1998 | A |
5915379 | Wallace et al. | Jun 1999 | A |
5942986 | Shabot et al. | Aug 1999 | A |
6050940 | Braun et al. | Apr 2000 | A |
6095984 | Amano et al. | Aug 2000 | A |
6160478 | Jacobsen | Dec 2000 | A |
6174283 | Nevo et al. | Jan 2001 | B1 |
6188407 | Smith et al. | Feb 2001 | B1 |
6269812 | Wallace et al. | Aug 2001 | B1 |
6287452 | Allen et al. | Sep 2001 | B1 |
6322502 | Schoenberg et al. | Nov 2001 | B1 |
6369838 | Wallace et al. | Apr 2002 | B1 |
6429869 | Kamakura et al. | Aug 2002 | B1 |
6614349 | Proctor et al. | Sep 2003 | B1 |
6727818 | Wildman et al. | Apr 2004 | B1 |
6804656 | Rosenfeld et al. | Oct 2004 | B1 |
7015816 | Wildman et al. | Mar 2006 | B2 |
7122005 | Shusterman | Oct 2006 | B2 |
7154397 | Zerhusen et al. | Dec 2006 | B2 |
7237287 | Weismiller et al. | Jul 2007 | B2 |
7323991 | Eckert et al. | Jan 2008 | B1 |
7408470 | Wildman et al. | Aug 2008 | B2 |
7420472 | Tran | Sep 2008 | B2 |
7430608 | Noonan et al. | Sep 2008 | B2 |
7502498 | Wen et al. | Mar 2009 | B2 |
7612679 | Fackler et al. | Nov 2009 | B1 |
7669263 | Menkedick et al. | Mar 2010 | B2 |
7715387 | Schuman | May 2010 | B2 |
7724147 | Brown | May 2010 | B2 |
7756723 | Rosow et al. | Jul 2010 | B2 |
7890349 | Cole et al. | Feb 2011 | B2 |
7895055 | Schneider et al. | Feb 2011 | B2 |
7908153 | Scherpbier et al. | Mar 2011 | B2 |
7945457 | Zaleski | May 2011 | B2 |
7962544 | Torok et al. | Jun 2011 | B2 |
7972140 | Renaud | Jul 2011 | B2 |
8108036 | Tran | Jan 2012 | B2 |
8123685 | Brauers et al. | Feb 2012 | B2 |
8224108 | Steinberg et al. | Jul 2012 | B2 |
8237558 | Seyed Momen et al. | Aug 2012 | B2 |
8273018 | Fackler et al. | Sep 2012 | B1 |
8432263 | Kunz | Apr 2013 | B2 |
8451314 | Cline et al. | May 2013 | B1 |
8529448 | McNair | Sep 2013 | B2 |
8565500 | Neff | Oct 2013 | B2 |
8620682 | Bechtel et al. | Dec 2013 | B2 |
8655680 | Bechtel et al. | Feb 2014 | B2 |
8700423 | Eaton, Jr. et al. | Apr 2014 | B2 |
8727981 | Bechtel et al. | May 2014 | B2 |
8769153 | Dziubinski | Jul 2014 | B2 |
8890937 | Skubic et al. | Nov 2014 | B2 |
8902068 | Bechtel et al. | Dec 2014 | B2 |
8917186 | Grant | Dec 2014 | B1 |
8953886 | King et al. | Feb 2015 | B2 |
9072929 | Rush et al. | Jul 2015 | B1 |
9129506 | Kusens | Sep 2015 | B1 |
9147334 | Long et al. | Sep 2015 | B2 |
9159215 | Kusens | Oct 2015 | B1 |
9269012 | Fotland | Feb 2016 | B2 |
9292089 | Sadek | Mar 2016 | B1 |
9305191 | Long et al. | Apr 2016 | B2 |
9408561 | Stone et al. | Aug 2016 | B2 |
9489820 | Kusens | Nov 2016 | B1 |
9519969 | Kusens | Dec 2016 | B1 |
9524443 | Kusens | Dec 2016 | B1 |
9536310 | Kusens | Jan 2017 | B1 |
9538158 | Rush et al. | Jan 2017 | B1 |
9563955 | Kamarshi et al. | Feb 2017 | B1 |
9597016 | Stone et al. | Mar 2017 | B2 |
9729833 | Kusens | Aug 2017 | B1 |
9741227 | Kusens | Aug 2017 | B1 |
9892310 | Kusens et al. | Feb 2018 | B2 |
9892311 | Kusens et al. | Feb 2018 | B2 |
9892611 | Kusens | Feb 2018 | B1 |
9905113 | Kusens | Feb 2018 | B2 |
20020015034 | Malmborg | Feb 2002 | A1 |
20020077863 | Rutledge et al. | Jun 2002 | A1 |
20020101349 | Rojas, Jr. | Aug 2002 | A1 |
20020115905 | August | Aug 2002 | A1 |
20020183976 | Pearce | Dec 2002 | A1 |
20030037786 | Biondi et al. | Feb 2003 | A1 |
20030070177 | Kondo et al. | Apr 2003 | A1 |
20030092974 | Santoso et al. | May 2003 | A1 |
20030095147 | Daw | May 2003 | A1 |
20030135390 | O'Brien et al. | Jul 2003 | A1 |
20030140928 | Bui et al. | Jul 2003 | A1 |
20030227386 | Pulkkinen et al. | Dec 2003 | A1 |
20040019900 | Knightbridge et al. | Jan 2004 | A1 |
20040052418 | DeLean | Mar 2004 | A1 |
20040054760 | Ewing et al. | Mar 2004 | A1 |
20040097227 | Siegel | May 2004 | A1 |
20040116804 | Mostafavi | Jun 2004 | A1 |
20040193449 | Wildman et al. | Sep 2004 | A1 |
20050038326 | Mathur | Feb 2005 | A1 |
20050182305 | Hendrich | Aug 2005 | A1 |
20050231341 | Shimizu | Oct 2005 | A1 |
20050249139 | Nesbit | Nov 2005 | A1 |
20060004606 | Wendl | Jan 2006 | A1 |
20060047538 | Condurso et al. | Mar 2006 | A1 |
20060049936 | Collins et al. | Mar 2006 | A1 |
20060058587 | Heimbrock et al. | Mar 2006 | A1 |
20060089541 | Braun et al. | Apr 2006 | A1 |
20060092043 | Lagassey | May 2006 | A1 |
20060107295 | Margis et al. | May 2006 | A1 |
20060145874 | Fredriksson et al. | Jul 2006 | A1 |
20060261974 | Albert et al. | Nov 2006 | A1 |
20070085690 | Tran | Apr 2007 | A1 |
20070118054 | Pinhas et al. | May 2007 | A1 |
20070120689 | Zerhusen et al. | May 2007 | A1 |
20070129983 | Scherpbier et al. | Jun 2007 | A1 |
20070136218 | Bauer et al. | Jun 2007 | A1 |
20070159332 | Koblasz | Jul 2007 | A1 |
20070279219 | Warriner | Dec 2007 | A1 |
20070296600 | Dixon et al. | Dec 2007 | A1 |
20080001763 | Raja et al. | Jan 2008 | A1 |
20080002860 | Super et al. | Jan 2008 | A1 |
20080004904 | Tran | Jan 2008 | A1 |
20080009686 | Hendrich | Jan 2008 | A1 |
20080015903 | Rodgers | Jan 2008 | A1 |
20080071210 | Moubayed | Mar 2008 | A1 |
20080087719 | Sahud | Apr 2008 | A1 |
20080106374 | Sharbaugh | May 2008 | A1 |
20080126132 | Warner et al. | May 2008 | A1 |
20080228045 | Gao | Sep 2008 | A1 |
20080249376 | Zaleski | Oct 2008 | A1 |
20080267447 | Kelusky et al. | Oct 2008 | A1 |
20080277486 | Seem et al. | Nov 2008 | A1 |
20080281638 | Watherly | Nov 2008 | A1 |
20090082829 | Panken et al. | Mar 2009 | A1 |
20090091458 | Deutsch | Apr 2009 | A1 |
20090099480 | Salgo et al. | Apr 2009 | A1 |
20090112630 | Collins, Jr. et al. | Apr 2009 | A1 |
20090119843 | Rodgers et al. | May 2009 | A1 |
20090177327 | Turner | Jul 2009 | A1 |
20090224924 | Thorp | Sep 2009 | A1 |
20090278934 | Ecker et al. | Nov 2009 | A1 |
20090322513 | Hwang et al. | Dec 2009 | A1 |
20100117836 | Seyed Momen et al. | May 2010 | A1 |
20100169114 | Henderson et al. | Jul 2010 | A1 |
20100169120 | Herbst et al. | Jul 2010 | A1 |
20100172567 | Prokoski | Jul 2010 | A1 |
20100176952 | Bajcsy et al. | Jul 2010 | A1 |
20100188228 | Hyland | Jul 2010 | A1 |
20100205771 | Pietryga et al. | Aug 2010 | A1 |
20100245577 | Yamamoto et al. | Sep 2010 | A1 |
20100285771 | Peabody | Nov 2010 | A1 |
20100305466 | Corn | Dec 2010 | A1 |
20110018709 | Kornbluh | Jan 2011 | A1 |
20110022981 | Mahajan et al. | Jan 2011 | A1 |
20110025493 | Papadopoulos et al. | Feb 2011 | A1 |
20110025499 | Hoy et al. | Feb 2011 | A1 |
20110035057 | Receveur et al. | Feb 2011 | A1 |
20110035466 | Panigrahi | Feb 2011 | A1 |
20110054936 | Cowan et al. | Mar 2011 | A1 |
20110068930 | Wildman et al. | Mar 2011 | A1 |
20110077965 | Nolte et al. | Mar 2011 | A1 |
20110087079 | Aarts | Apr 2011 | A1 |
20110087707 | Aarts | Apr 2011 | A1 |
20110102133 | Shaffer | May 2011 | A1 |
20110102181 | Metz | May 2011 | A1 |
20110106560 | Eaton, Jr. et al. | May 2011 | A1 |
20110106561 | Eaton, Jr. et al. | May 2011 | A1 |
20110175809 | Markovic | Jul 2011 | A1 |
20110190593 | McNair | Aug 2011 | A1 |
20110227740 | Wohltjen | Sep 2011 | A1 |
20110254682 | Sigrist Christensen | Oct 2011 | A1 |
20110288811 | Greene | Nov 2011 | A1 |
20110295621 | Farooq | Dec 2011 | A1 |
20110301440 | Riley | Dec 2011 | A1 |
20110313325 | Cuddihy | Dec 2011 | A1 |
20120025991 | O'Keefe et al. | Feb 2012 | A1 |
20120026308 | Johnson et al. | Feb 2012 | A1 |
20120075464 | Derenne et al. | Mar 2012 | A1 |
20120092162 | Rosenberg | Apr 2012 | A1 |
20120098918 | Murphy | Apr 2012 | A1 |
20120154582 | Johnson et al. | Jun 2012 | A1 |
20120212582 | Deutsch | Aug 2012 | A1 |
20120259650 | Mallon et al. | Oct 2012 | A1 |
20130027199 | Bonner | Jan 2013 | A1 |
20130120120 | Long et al. | May 2013 | A1 |
20130122807 | Tenarvitz et al. | May 2013 | A1 |
20130184592 | Venetianer | Jul 2013 | A1 |
20130309128 | Voegeli et al. | Nov 2013 | A1 |
20130332184 | Burnham et al. | Dec 2013 | A1 |
20140039351 | Mix et al. | Feb 2014 | A1 |
20140070950 | Snodgrass | Mar 2014 | A1 |
20140085501 | Tran | Mar 2014 | A1 |
20140155755 | Pinter | Jun 2014 | A1 |
20140191861 | Scherrer | Jul 2014 | A1 |
20140267625 | Clark et al. | Sep 2014 | A1 |
20140327545 | Bolling et al. | Nov 2014 | A1 |
20140333744 | Baym et al. | Nov 2014 | A1 |
20140354436 | Nix et al. | Dec 2014 | A1 |
20140365242 | Neff | Dec 2014 | A1 |
20150109442 | Derenne et al. | Apr 2015 | A1 |
20150206415 | Wegelin et al. | Jul 2015 | A1 |
20150269318 | Neff | Sep 2015 | A1 |
20150278456 | Bermudez Rodriguez et al. | Oct 2015 | A1 |
20160022218 | Hayes et al. | Jan 2016 | A1 |
20160070869 | Portnoy et al. | Mar 2016 | A1 |
20160093195 | Ophardt | Mar 2016 | A1 |
20160127641 | Gove | May 2016 | A1 |
20160253802 | Venetianer et al. | Sep 2016 | A1 |
20160267327 | Franz et al. | Sep 2016 | A1 |
20170055917 | Stone et al. | Mar 2017 | A1 |
20170109991 | Kusens | Apr 2017 | A1 |
20170143240 | Stone et al. | May 2017 | A1 |
Number | Date | Country |
---|---|---|
19844918 | Apr 2000 | DE |
2009018422 | Feb 2009 | WO |
2012122002 | Sep 2012 | WO |
Entry |
---|
Non-Final Office Action dated Oct. 7, 2015 in U.S. Appl. No. 14/339,397, 16 pages. |
Non-Final Office Action dated Mar. 11, 2016 in U.S. Appl. No. 14/575,850, 10 pages. |
Pending U.S. Application by same inventor Neal Kusens. U.S. Appl. No. 14/611,363, filed Feb. 2, 2015, entitled “Method and System for Determining Whether an Individual Takes Appropriate Measures to Prevent the Spread of Healthcare Associated Infections”. |
Non-Final Office Action dated May 23, 2016 in U.S. Appl. No. 14/743,499, 5 pages. |
Notice of Allowance dated May 31, 2016 in U.S. Appl. No. 14/743,447, 8 pages. |
Notice of Allowance dated Jun. 22, 2016 in U.S. Appl. No. 14/743,447, 4 pages. |
Notice of Allowance dated Jun. 27, 2016 in U.S. Appl. No. 14/728,762, 14 pages. |
Notice of Allowance dated Jun. 5, 2015 in U.S. Appl. No. 13/543,816, 5 pages. |
Pending U.S. Application by same inventor Neal Kusens, U.S. Appl. No. 14/613,866, filed Feb. 4, 2015, entitled “Method and System for Determining Whether an Individual Takes Appropriate Measures to Prevent the Spread of Healthcare Associated Infections Along With Centralized Monitoring”. |
Notice of Allowance dated Jul. 18, 2016 in U.S. Appl. No. 14/743,264, 16 pages. |
Final Office Action dated Jul. 28, 2016 in U.S. Appl. No. 14/723,969, 26 pages. |
Tom Mooney, “Rhode Island ER first to test Google Glass on medical conditions”, http://www.ems1.com/ems-products/cameras-video/articles/1860487-Rhode-Island-ER-first... printed on Mar. 11, 2014. |
Pending U.S. Application by same inventor Neil Kusens, U.S. Appl. No. 14/084,588, filed Nov. 19, 2013, entitled “Method for Determining Whether an Individual Leaves a Prescribed Virtual Perimeter”. |
Pending U.S. Application by same inventor Neil Kusens, U.S. Appl. No. 14/575,850, filed Dec. 18, 2014, entitled “Method and Process for Determining Whether an Individual Suffers a Fall Requiring Assistance”. |
Pending U.S. Application by same inventor Neil Kusens, U.S. Appl. No. 14/599,498, filed Jan. 17, 2015, entitled “Method and System for Determining Whether an Individual Takes Appropriate Measures to Prevent the Spread of Healthcare Associated Infections”. |
Pending U.S. Application by same inventor Neil Kusens, U.S. Appl. No. 14/611,363, filed Feb. 2, 2015, entitled “Method and System for Determining Whether an Individual Takes Appropriate Measures to Prevent the Spread of Healthcare Associated Infections”. |
Pending U.S. Application by same inventor Neil Kusens, U.S. Appl. No. 14/613,866, filed Feb. 4, 2015, entitled “Method and System for Determining Whether an Individual Takes Appropriate Measures to Prevent the Spread of Healthcare Associated Infections Along With Centralized Monitoring”. |
Pending U.S. Application by same inventor Neil Kusens, U.S. Appl. No. 14/724,969, filed May 29, 2015, entitled “Method and Process for Determining Whether an Individual Suffers a Fall Requiring Assistance”. |
Pending U.S. Application by same inventor Neil Kusens, U.S. Appl. No. 13/543,816, filed Jul. 7, 2012, entitled “Method and Process for Determining Whether an Individual Suffers a Fall Requiring Assistance”. |
Pending U.S. Application by same inventor Neil Kusens, U.S. Appl. No. 14/727,434, filed Jun. 1, 2015, entitled Method for Determining Whether Enters a Prescribed Virtual Zone Using Skeletal Tracking and 3D Blob Detection. |
Pending U.S. Application by same inventor Neil Kusens, U.S. Appl. No. 14/728,762, filed Jun. 2, 2015, entitled “Method for Determining Whether an Individual Leaves a Prescribed Virtual Perimeter”. |
Pending U.S. Application by same inventor Neil Kusens, U.S. Appl. No. 14/743,264, filed Jun. 18, 2015, entitled “System for Determining Whether an Individual Enters a Prescribed Virtual Zone Using 3D Blob Detection”. |
Pending U.S. Application by same inventor Neil Kusens, U.S. Appl. No. 14/743,499, filed Jun. 18, 2015, entitled “System for Determining Whether an Individual Suffers a Fall Requiring Assistance”. |
Pending U.S. Application by same inventor Neil Kusens, U.S. Appl. No. 14/743,447, filed Jun. 18, 2015, entitled “System for Determining Whether an Individual Suffers a Fall Requiring Assistance”. |
Notice of Allowance dated Dec. 23, 2016 in U.S. Appl. No. 14/724,969, 5 pages. |
Non-Final Office Action dated Jan. 11, 2017 in U.S. Appl. No. 14/611,363, 19 pages. |
Non-Final Office Action dated Feb. 23, 2017 in U.S. Appl. No. 14/757,877, 24 pages. |
First Action Interview Preinterview Communication dated Feb. 24, 2017 in U.S. Appl. No. 15/395,716, 5 pages. |
Notice of Allowance dated Mar. 20, 2017 in U.S. Appl. No. 14/613,866, 11 pages. |
Non-Final Office Action dated Apr. 11, 2017 in U.S. Appl. No. 15/285,416, 13 pages. |
Notice of Allowance dated Apr. 19, 2017 in U.S. Appl. No. 15/395,716, 5 pages. |
Non-Final Office Action dated Apr. 21, 2017 in U.S. Appl. No. 14/757,593, 9 pages. |
Notice of Allowance dated Apr. 21, 2017 in U.S. Appl. No. 14/724,969, 9 pages. |
Notice of Allowance dated Apr. 25, 2017 in U.S. Appl. No. 14/727,434, 9 pages. |
Final Office Action dated Apr. 28, 2017 in U.S. Appl. No. 14/611,363, 20 pages. |
Non-Final Office Action dated May 31, 2017 in U.S. Appl. No. 14/599,498, 24 pages. |
Notice of Allowance dated Jul. 5, 2017 in U.S. Appl. No. 14/727,434, 9 pages. |
Non-Final Office Action dated Sep. 23, 2016 in U.S. Appl. No. 14/727,434, 9 pages. |
Non-Final Office Action dated Apr. 27, 2017 in U.S. Appl. No. 15/395,526, 16 pages. |
Non-Final Office Action dated May 8, 2017 in U.S. Appl. No. 15/395,250, 19 pages. |
Notice of Allowance dated Jul. 24, 2017 in U.S. Appl. No. 15/395,716, 5 pages. |
Non-Final Office Action dated Aug. 16, 2017 in U.S. Appl. No. 14/757,593, 8 pages. |
Final Office Action dated Aug. 23, 2017 in U.S. Appl. No. 15/285,416, 16 pages. |
Notice of Allowance dated Sep. 21, 2017 in U.S. Appl. No. 15/395,526, 13 pages. |
Notice of Allowance dated Sep. 26, 2017 in U.S. Appl. No. 15/395,250, 13 pages. |
Final Office Action dated Sep. 29, 2017 in U.S. Appl. No. 14/757,877, 22 pages. |
Notice of Allowance dated Oct. 10, 2017 in U.S. Appl. No. 14/727,434, 9 pages. |
Final Office Action dated Oct. 12, 2017 in U.S. Appl. No. 14/599,498, 28 pages. |
Notice of Allowance dated Oct. 20, 2017 in U.S. Appl. No. 15/279,054, 14 pages. |
First Action Interview Pre-Interview Communication dated Nov. 22, 2017 in U.S. Appl. No. 15/134,189, 4 pages. |
Virtual Patient Observation: Centralize Monitoring of High-Risk Patients with Video- Cisco Video Surveillance Manager, https://www.cisco.com/c/en/us/products/collateral/physical-security/video-surveillance-manager/white paper_C11-715263.pdf. |
Notice of Allowance dated Dec. 6, 2017 in U.S. Appl. No. 15/395,716, 5 pages. |
Final Office Action dated Dec. 12, 2017 in U.S. Appl. No. 14/575,850, 10 pages. |
Notice of Allowance dated Dec. 29, 2017 in U.S. Appl. No. 14/611,363, 11 pages. |
Non-Final Office Action dated Mar. 12, 2018 in U.S. Appl. No. 15/285,416, 20 pages. |
Non-Final Office Action dated May 2, 2018 in U.S. Appl. No. 15/728,110, 8 pages. |
Non-Final Office Action dated May 7, 2018 in U.S. Appl. No. 14/611,363, 6 pages. |
Non-Final Office Action dated May 8, 2018 in U.S. Appl. No. 15/148,151, 5 pages. |
Notice of Allowance dated May 9, 2018 in U.S. Appl. No. 15/395,716, 5 pages. |
Raheja, et al., “Human Facial Expression Detection From Detected in CapturedImage Using Back Progagation Neural Network”, International Journal of Computer Science and Information Technology (IJCSIT), vol. 2, No. 1, Feb. 2010, 8 pages. |
Notice of Allowance dated Aug. 26, 2016 in U.S. Appl. No. 14/743,447, 5 pages. |
Notice of Allowance dated Sep. 19, 2016 in U.S. Appl. No. 14/743,499, 5 pages. |
Notice of Allowance dated Oct. 14, 2016 in U.S. Appl. No. 14/743,264, 14 pages. |
Notice of Allowance dated Nov. 9, 2016 in U.S. Appl. No. 14/743,264, 14 pages. |
Notice of Allowance dated Nov. 14, 2016 in U.S. Appl. No. 14/743,447, 5 pages. |
Final Office Action dated Jul. 12, 2018 in U.S. Appl. No. 15/134,189, 23 pages. |
Final Office Action dated Jul. 5, 2018 in U.S. Appl. No. 15/285,416, 8 pages. |
First Action Interview Pre-Interview Communication dated May 21, 2018 in U.S. Appl. No. 15/910,645, 14 pages. |
Non-Final Office Action dated Jun. 8, 2018 in U.S. Appl. No. 15/628,318, 9 new pages. |
Non-Final Office Action dated May 31, 2018 in U. S. Appl. No. 15/39,762, 24 pages. |
Non-Final Office Action dated May 31, 2018 in U.S. Appl. No. 15/848,621, 23 pages. |
Notice of Allowance dated Jul. 13, 2018 in U.S. Appl. No. 15/396,263, 9 pages. |
Notice of Allowance dated Jul. 18, 2018 in U.S. Appl. No. 14/599,498, 6 pages. |
Notice of Allowance dated Jul. 23, 2018 in U.S. Appl. No. 15/728,110, 15 pages. |
Notice of Allowance dated Jun. 13, 2018 in U.S. Appl. No. 14/575,850, 5 pages. |
Notice of Allowance dated Jun. 19, 2018 in U.S. Appl. No. 15/395,716, 2 pages. |
Notice of Allowance dated Jun. 4, 2018 in U.S. Appl. No. 14/757,593, 5 pages. |
Non-Final Office Action dated Aug. 15, 2018 in U.S. Appl. No. 15/910,632, 7 pages. |